Navigation Links
Stem Cells Speed Growth of Healthy Liver Tissue

OAK BROOK, Ill.—For the first time, researchers have used adult bone marrow stem cells to regenerate healthy human liver tissue,// according to a study published in the April issue of the journal Radiology.

When large, fast-growing cancers invade the liver, some patients are unable to undergo surgery, because removing the cancerous tissue would leave too little liver to support the body.

Researchers at Heinrich-Heine-University in Düsseldorf, Germany, used adult bone marrow stem cells to help quickly regenerate healthy liver tissue, enabling patients to eventually undergo a surgical resection.

“Our study suggests that liver stem cells harvested from the patient’s own bone marrow can further augment and accelerate the liver’s natural capacity to regenerate itself,” said Günther Fürst, M.D., co-author and professor of radiology.

In the study, researchers compared the results of portal vein embolization (PVE), a technique currently used to help regenerate liver tissue, to a combination of PVE and an injection of bone marrow stem cells into the liver.

PVE blocks blood flow to the diseased portion of the liver and diverts blood to the organ’s healthy tissue, promoting liver growth. Bone marrow stem cells extracted from the patient’s hip bone and injected into the liver also help the liver regenerate.

The study included 13 patients with large central liver malignancies who were unable to undergo surgery because resection would leave less than 25 percent of their total liver volume.

Six of the patients underwent both PVE and injection of bone marrow stem cells. Seven patients underwent only PVE. Computed tomography (CT) scans were performed before and up to five weeks after PVE to determine the degree of liver growth.

Patients who received the combination of PVE and stem cell injection had double the liver growth rate and gain in liver volume, compared with those who underw
'"/>




Page: 1 2

Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. White Cells Count Can Predict Heart Attack Death Risk
3. Gene Therapy Destroys Pancreatic Cancer Cells
4. Stem Cells Have Few Mutations
5. Heart may pull Cells from Body to Self-repair
6. Cells critical for asthma development found
7. Vitamin D Wipes out Cancer Cells
8. Bone Marrow Cells Help Heart Attack Patients
9. Islet Cells May Lead to Diabetes CureChildren
10. Stem Cells Found To Offer Promise For Hair Growth
11. Bone Marrow Cells Could Yield A New Lease of Life
Post Your Comments:
(Date:11/21/2008)... Roseanne Roseannadana would. So wou...ving with cancer, and those who support them, can ...k City by paying for everyday purchases with the n... NEW YORK (Business Wire EO...0 for every activated card, plus an ongoing share ...
(Date:11/21/2008)...the collaboration of Baxa Corporation, ClinicalIQ ...understanding of, and compliance to, USP < 797 ...WOOD, Colo., Nov. 21 Baxa Corporat..., LLC and Pharmacy OneSource, Inc. to convey a com...n United States Pharmacopeia (USP) < 797 > r...
(Date:11/21/2008)...ov. 21 Keryx Biopharmace...at on November 17, 2008, it received notice from T... Company is no longer in compliance with Marketpla...have a minimum of $2,500,000 in stockholders, equi...es, or $500,000 of net income from continuing oper...
(Date:11/21/2008)...nd TOKYO, Nov. 21 DATATR...ology and services company focused,on global eCli...today reported,that its alliance partner in Japan...-designed project using the DATATRAK eClinical pla...al. The successful rollout of this first,indepen...
Breaking Medicine News(10 mins):Health News: Gilda's Club NYC Offers Affinity Credit Card to Help New Yorkers Living with Cancer 2Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 2Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 3Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 4Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 2Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 3Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 2Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 3
... nearly all deaths due to asthma can be prevented ...standing of the disease. According to WHO, around ...d nearly 2 lakh people die due to the disease ever...often linked with allergies, that is characterized...
...l Association has asked its members to refrain fro...male foeticide. No support would be extended to p...nday. "We as an organisation should warn our membe...", said Dr. Vinay Agarwal, joint secretary, IMA he...
...anta, Georgia, have opined after an exhaustive stu...conducted on 25 men and women and studied their re...of Emory University led the study. The fact that s...rs thrive on never knowing what the day will bring...
... saves heroin addicts from overdose and it is advi... for life saving emergencies, according to doctors...one, is routinely given by doctors, during emergen...narcotic overdose. After giving 124 drug users in ...
Other Medicine News:
(Date:11/20/2008)...20 The following is bei...ty: , , WHAT: World AIDS Day Audio Media ...mber 25, 2008 , 11:00 a.m. EST , Call-in num... https://cc.readytalk.com/r/1xe41i2yre8rs , ...number of people newly put on treatment worldwide,...
(Date:11/20/2008)...zerland, November 20 Arp...ective Drugs Advisory Committee of the,U.S. Food ...ainst the,approval of intravenous iclaprim, an an...nt of patients with complicated skin and skin stru... by methicillin-resistant Staphylococcus,aureus (...
(Date:11/20/2008)... Nov. 20 Radius Health ("Radius") ...15 million to its second institutional financing r...5 million and the total amount raised since the co...institutional investors participated in the financ...uding MPM Capital, The Wellcome Trust, HealthCare ...
(Date:11/19/2008)...v. 19 Posit Science Corporation,r...ociety for Neuroscience,Annual Conference in Wash...aining may benefit Baby Boomers. The computerized...) uses adaptive exercises that target auditory and... drive generalized,improvements in cognition by i...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Chem Rx Corporation Schedules 2008 Annual Meeting Date 28466 1Chem Rx Corporation Schedules 2008 Annual Meeting Date 28466 2New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 1New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 2New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 3Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 1Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 2Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 3Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 4Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 5Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements 8791 1Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements 8791 2
...ANCISCO, Calif., April 03, 2007,/PRNewswire-FirstC...updated results from its second multi-center Phase... which evaluated escalating doses,of the immunothe...tory prostate cancer (HRPC). Additional follow-up ...omparable to that,being employed in the company,s ...
...if.--(BUSINESS WIRE)--Apr 3, 2007 - Arrowhead Rese...ication by its,majority-owned subsidiary Calando P...anti-proliferative effect of the siRNA sequence,se...ti-cancer,compound, CALAA-01., The paper, entitled...ase Subunit RRM2 Reduce Cell Proliferation In vitr...
Other Medicine Technology:Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
Standard Deflectable Catheters
The Explorer ST "soft tip" catheter has a proximal shaft with a soft tip. It is available in both a 5F and 6F shaft configuration.
...flectable curve catheters designed to specifically...ents with small anatomies. Each catheter is handcr...inest materials. A unique multi-step process that ...chnologies results in the excellent torque and fle...
A-Focus I & II Catheters. A-Focus steerable atrial mapping catheter. Available in 10, 12, 14 and 20 electrode configurations. (Shown with 14 electrodes).
Medicine Products: